logo

For the Inventor, By the Inventor

The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Patent No.:

US 9433596 B1

PDFFull Text
Date of Patent:
Sep. 06, 2016

Filed:

Sep. 06, 2010

Pharmaceutical composition comprising n-acetyl-l-cysteine or its derivatives for treating anxiety disorder

Applicants:

Suk Woo Choi, Seoul, KR;

Suk Won Lee, Seoul, KR;

Jeong Yeon Kim, Seoul, KR;

Beom Jong Song, Seoul, KR;

IN Gie Hong, Seoul, KR;

Sung MO Park, Seoul, KR;

Ji Hye Kim, Seoul, KR;

Jun Uk Lee, Seoul, KR;

BO Bae an, Seoul, KR;

Inventors:

Suk Woo Choi, Seoul, KR;

Suk Won Lee, Seoul, KR;

Jeong Yeon Kim, Seoul, KR;

Beom Jong Song, Seoul, KR;

In Gie Hong, Seoul, KR;

Sung Mo Park, Seoul, KR;

Ji Hye Kim, Seoul, KR;

Jun Uk Lee, Seoul, KR;

Bo Bae An, Seoul, KR;

Assignee:

SNU R&DB FOUNDATION, Seoul, KR;

Attorneys:

Vorys, Sater, Seymour & Pease LLP

Mih Suhn Koh

Primary Examiner:

Sahar Javanmard

Int. Cl.
CPC ...
A61K 31/198 (2006.01); A61K 31/195 (2006.01); A61K 31/355 (2006.01); A61K 31/51 (2006.01); A61K 31/525 (2006.01); A61K 45/06 (2006.01); A61K 38/05 (2006.01); A61K 38/17 (2006.01); A61K 38/18 (2006.01); A61K 38/21 (2006.01); A61K 31/18 (2006.01); A61K 31/216 (2006.01); A61K 31/55 (2006.01); A61K 31/5513 (2006.01); A61K 31/702 (2006.01);
U.S. Cl.
CPC ...
A61K 31/198 (2013.01); A61K 31/18 (2013.01); A61K 31/195 (2013.01); A61K 31/216 (2013.01); A61K 31/355 (2013.01); A61K 31/51 (2013.01); A61K 31/525 (2013.01); A61K 31/55 (2013.01); A61K 31/5513 (2013.01); A61K 31/702 (2013.01); A61K 38/05 (2013.01); A61K 38/1709 (2013.01); A61K 38/1825 (2013.01); A61K 38/1833 (2013.01); A61K 38/1866 (2013.01); A61K 38/21 (2013.01); A61K 45/06 (2013.01);
Abstract

The present disclosure relates to a composition for treating anxiety disorder, particularly to a pharmaceutical composition comprising N-acetyl-L-cysteine or its derivatives for treating anxiety disorder such as post traumatic stress disorder or phobia. In accordance with the present disclosure, N-acetyl-L-cysteine can block the renewal of fear memories for a sustained period of time when it was administered during or after an exposure therapy to treat post traumatic stress disorder or phobia.

Find Patent Forward Citations

Loading…